Metaxalone
- Product NDC
- 43063-239
- 11-digit product format
- 430630239
- Labeler code
- 43063
- Product ID
- 43063-239_a033aaaa-c085-7d81-e053-2a95a90a7da9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- NDA013217
- Marketing category
- NDA
- Marketing start
- 2007-11-01
- Marketing end
- 2020-04-01
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43063-239-10 | EA - Each | 43063-239 | 751fcb09-a05b-421c-af1a-789bc1e43676 | 1 | 2012-07-24 |
| 43063-239-15 | EA - Each | 43063-239 | a9175ef3-1e22-4f09-aeda-3456b1283726 | 1 | 2012-07-24 |
| 43063-239-20 | EA - Each | 43063-239 | ac90b390-f20e-40e7-86af-565d05424481 | 1 | 2012-07-24 |
| 43063-239-21 | EA - Each | 43063-239 | 2cf55937-440d-43b7-ac6c-6472f28850fd | 1 | 2012-07-24 |
| 43063-239-30 | EA - Each | 43063-239 | 92593acb-c255-444d-be5f-2b76e82abab7 | 1 | 2012-07-24 |
| 43063-239-40 | EA - Each | 43063-239 | 8da6727c-b331-47d5-a381-4458a5aaa8ac | 1 | 2012-07-24 |
| 43063-239-60 | EA - Each | 43063-239 | aa17f77b-88fd-4a49-b2e0-7dee7395be9b | 1 | 2015-02-02 |
| 43063-239-90 | EA - Each | 43063-239 | ddeb8c6b-75bf-436a-80b3-048d5305bb78 | 1 | 2015-02-02 |
| 43063-239-98 | EA - Each | 43063-239 | 4c3173d3-da50-4e41-83bb-abe36a9d7ae9 | 1 | 2015-02-02 |